systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-160Research ArticleСТАТЬИARTICLESМесто низкодозовых фиксированных комбинаций антигипертензивных препаратов у пациентов с артериальной гипертониейРатоваЛ. Г.noemail@neicon.ruЧазоваИ. Е.noemail@neicon.ruФГУ РКНПК Федерального агентства по высокотехнологичной медицинской помощи, МоскваRussian Federation200823122022541214Copyright © Ратова Л.Г., Чазова И.Е., 20222022Ратова Л.Г., Чазова И.Е.Ратова Л.Г., Чазова И.Е.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/160ReferencesДиагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; Прил. 2.Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; Прил. 2.Kaplan N, Opie LH. Antihypertensive drugs. Ed.: L.Opie, Drugs for the heart, 4th ed. Philadelphia: W.B. Saunders, 1995.Kaplan N, Opie LH. Antihypertensive drugs. Ed.: L.Opie, Drugs for the heart, 4th ed. Philadelphia: W.B. Saunders, 1995.Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154 (13): 1461-8.Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154 (13): 1461-8.Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35 (2): 182-8.Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35 (2): 182-8.Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313-21.Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313-21.Benetos A, Adamopoulos C, Argyriadis P et al. Clinical results with bisoprolol 2,5 mg/hydrochlorothiazide 6,25 mg combination in systolic hypertension in the elderly. Hypertens Suppl 2002; 20 (1): 21-5.Benetos A, Adamopoulos C, Argyriadis P et al. Clinical results with bisoprolol 2,5 mg/hydrochlorothiazide 6,25 mg combination in systolic hypertension in the elderly. Hypertens Suppl 2002; 20 (1): 21-5.
The authors declare that there are no conflicts of interest present.